◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
BLOOMAGE BIOTECHNOLOGY CORPORAT — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016
+Revenue 5.4B 6.1B 6.4B 4.9B 2.6B 1.9B 1.3B 818.0M 733.0M
Revenue Growth % -11.6% -4.5% 28.5% 87.9% 39.6% 49.3% 54.4% 11.6% --
Total Revenue 5.4B 6.1B 6.4B 4.9B 2.6B 1.9B 1.3B 818.0M 733.0M
Cost Of Revenue 1.4B 1.6B 1.5B 1.1B 489.0M 384.0M 254.0M 201.0M 166.0M
+Gross Profit 4.0B 4.5B 4.9B 3.9B 2.1B 1.5B 1.0B 617.0M 567.0M
Gross Margin % 74.1% 73.3% 77.0% 78.1% 81.4% 79.6% 79.9% 75.4% 77.4%
Total Operating Cost 5.2B 5.5B 5.4B 4.2B 2.0B 1.2B 765.0M 561.0M 422.0M
Selling Expenses 2.5B 2.8B 3.0B 2.4B 1.1B 521.0M 284.0M 125.0M 107.0M
Admin Expenses 658.0M 492.0M 393.0M 303.0M 162.0M 182.0M 170.0M 175.0M 110.0M
Rd Expenses 466.0M 446.0M 388.0M 284.0M 141.0M 93.9M 52.9M 25.7M 24.0M
Finance Expenses -7.0M -30.8M -48.7M -494,700 -511,500 -12.5M -23.2M 15.6M -7.5M
+Operating Income 216.0M 708.0M 1.1B 906.0M 757.0M 700.0M 524.0M 284.0M 320.0M
Operating Margin % 4.0% 11.7% 17.9% 18.3% 28.8% 37.1% 41.5% 34.7% 43.7%
Non Operating Income 2.8M 2.9M 6.1M 1.7M 4.6M 6.2M 1.2M 84,100 10.4M
Non Operating Expenses 5.4M 9.5M 6.3M 17.1M 2.8M 4.7M 10.7M 319,200 929,500
Investment Income -12.5M 1.3M 11.9M 20.6M 34.2M 447,500 10.4M 15.2M 9.6M
Fair Value Change Income 1.4M 1.5M -142,600 7.4M 3.3M -- -- 381,000 --
Asset Disposal Income -118,900 -3.4M -488,700 42,800 53,100 31,500 -9,300 81,500 --
Asset Impairment Loss 159.0M 54.4M 15.4M 29.8M 16.3M 3.9M 714,800 -75,400 7.6M
Other Income 85.2M 131.0M 122.0M 133.0M 53.0M 22.6M 15.5M 11.5M --
Income Before Tax 213.0M 702.0M 1.1B 890.0M 759.0M 701.0M 515.0M 284.0M 330.0M
Income Tax 45.0M 119.0M 175.0M 115.0M 114.0M 116.0M 91.1M 61.8M 60.5M
+Net Income 168.0M 583.0M 961.0M 776.0M 645.0M 585.0M 424.0M 222.0M 269.0M
Net Margin % 3.1% 9.6% 15.1% 15.7% 24.5% 31.0% 33.6% 27.1% 36.7%
Net Income Attributable 174.0M 593.0M 971.0M 782.0M 646.0M 586.0M 424.0M 222.0M 269.0M
Minority Interest -5.9M -9.8M -9.5M -6.8M -828,100 -993,500 -- -- --
Eps Basic 0.36 1.23 2.02 1.63 1.35 1.34 -- -- --
Eps Diluted 0.36 1.23 2.01 1.62 1.35 1.34 -- -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016
Cash And Equivalents 719.0M 1.2B 1.6B 1.8B 1.4B 2.2B 854.0M 332.0M 558.0M
Trading Financial Assets 30.0M 140.0M 531.0M 847.0M 723.0M -- -- 381,000 --
Accounts Receivable 543.0M 447.0M 448.0M 397.0M 372.0M 372.0M 202.0M 153.0M 179.0M
Notes Receivable 1.3M -- -- 4.6M 4.8M 1.4M 21.6M 68.6M 38.9M
Notes And Accounts Receivable 544.0M 447.0M 448.0M 401.0M 377.0M 373.0M 224.0M 221.0M 218.0M
Prepayments 81.4M 150.0M 172.0M 88.2M 44.7M 37.1M 16.5M 7.3M 9.6M
Inventory 1.2B 1.1B 1.2B 709.0M 477.0M 315.0M 177.0M 140.0M 152.0M
Total Current Assets 2.7B 3.1B 4.0B 4.0B 3.7B 3.8B 1.3B 1.2B 981.0M
Long Term Equity Investment 417.0M 194.0M 68.2M 19.0M 17.9M 14.6M 14.5M -- --
Fixed Assets -- 2.4B 1.9B 1.6B 627.0M 460.0M 376.0M 374.0M 369.0M
Fixed Assets Total 3.3B 2.4B 1.9B 1.6B 627.0M 460.0M 376.0M 374.0M 369.0M
Construction In Progress -- 1.1B 830.0M 517.0M 618.0M 172.0M 85.7M 4.3M 16.3M
Construction In Progress Total 641.0M 1.1B 830.0M 517.0M 618.0M 172.0M 85.7M 4.3M 16.3M
Intangible Assets 491.0M 497.0M 475.0M 467.0M 427.0M 385.0M 163.0M 90.3M 69.3M
Long Term Deferred Expenses 100.0M 98.1M 116.0M 31.8M 15.6M 18.9M 6.2M 2.6M 566,700
Total Non Current Assets 5.9B 5.3B 4.7B 3.5B 2.1B 1.2B 774.0M 713.0M 703.0M
Total Assets 8.7B 8.5B 8.7B 7.5B 5.7B 5.0B 2.1B 1.9B 1.7B
Short Term Borrowings 49.9M -- 139.0M -- 24.1M -- 40.0M -- 220.0M
Accounts Payable 820.0M 694.0M 817.0M 644.0M 197.0M 95.0M 61.4M -- --
Advance Receipts -- -- -- -- -- 19.6M 12.3M 20.4M 10.6M
Contract Liabilities 63.5M 55.6M 67.7M 50.8M 43.4M -- -- -- --
Total Current Liabilities 1.3B 1.2B 1.6B 1.4B 553.0M 366.0M 291.0M 182.0M 383.0M
Long Term Borrowings 65.1M 2.3M 108.0M 144.0M -- -- -- -- --
Total Non Current Liabilities 476.0M 266.0M 355.0M 401.0M 146.0M 56.4M 62.2M 63.5M 40.5M
Total Liabilities 1.8B 1.5B 2.0B 1.8B 699.0M 422.0M 354.0M 245.0M 424.0M
Paid In Capital 482.0M 482.0M 481.0M 480.0M 480.0M 480.0M 430.0M 88.8M 88.8M
Capital Reserve 3.9B 3.8B 3.8B 3.6B 3.5B 3.5B 807.0M 487.0M 320.0M
Surplus Reserve 254.0M 254.0M 254.0M 254.0M 154.0M 90.7M 146.0M 106.0M 106.0M
Retained Earnings 2.4B 2.5B 2.2B 1.4B 934.0M 529.0M 333.0M 957.0M 748.0M
Minority Equity 29.6M 39.3M 49.2M 3.4M -1.6M -788,100 205,700 -- --
Equity Attributable 6.8B 6.9B 6.6B 5.7B 5.0B 4.5B 1.7B 1.6B 1.3B
Total Equity 6.8B 7.0B 6.7B 5.7B 5.0B 4.5B 1.7B 1.6B 1.3B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016
Cash From Sales 5.6B 6.5B 6.7B 5.3B 2.8B 1.8B 1.4B 909.0M 763.0M
Tax Refunds Received 44.0M 66.8M 113.0M 2.1M 38,300 824,100 6.8M -- --
Total Operating Cash Inflow 5.9B 6.8B 7.1B 5.5B 3.0B 1.9B 1.5B 918.0M 771.0M
Cash Paid For Goods 1.5B 1.6B 1.8B 1.1B 520.0M 416.0M 334.0M 134.0M 130.0M
Cash Paid To Employees 1.3B 1.2B 1.1B 708.0M 462.0M 355.0M 207.0M 144.0M 126.0M
Taxes Paid 524.0M 617.0M 884.0M 542.0M 369.0M 302.0M 228.0M 169.0M 151.0M
Total Operating Cash Outflow 5.3B 6.1B 6.4B 4.2B 2.3B 1.5B 1.0B 575.0M 529.0M
Operating Cash Flow 565.0M 700.0M 635.0M 1.3B 705.0M 365.0M 442.0M 343.0M 242.0M
Total Investing Cash Inflow 678.0M 1.8B 3.5B 5.1B 8.8B 5.8M 756.0M 1.1B 489.0M
Total Investing Cash Outflow 1.1B 2.4B 4.3B 6.1B 10.1B 1.3B 790.0M 1.5B 506.0M
Investing Cash Flow -461.0M -613.0M -836.0M -990.0M -1.3B -1.2B -34.5M -329.0M -17.7M
Cash From Borrowings 150.0M -- 138.0M 174.0M 23.8M -- 40.0M -- 220.0M
Dividends And Interest Paid 186.0M 305.0M 243.0M 201.0M 178.0M -- 1.0B 15.8M 11.5M
Debt Repayments 114.0M 106.0M 36.7M 16.2M -- 40.0M -- 220.0M --
Total Financing Cash Inflow 150.0M 57.7M 227.0M 184.0M 23.8M 2.3B 1.1B 5.0M 220.0M
Total Financing Cash Outflow 460.0M 585.0M 397.0M 255.0M 184.0M 65.0M 1.0B 236.0M 11.5M
Financing Cash Flow -311.0M -528.0M -170.0M -71.4M -160.0M 2.2B 85.2M -231.0M 208.0M
Net Change In Cash -200.0M -430.0M -342.0M 195.0M -798.0M 1.3B 509.0M -226.0M 438.0M
Ending Cash Balance 613.0M 813.0M 1.2B 1.6B 1.4B 2.2B 841.0M 332.0M 558.0M
Capex 721.0M 1.0B 696.0M 784.0M 763.0M 450.0M 168.0M 46.0M 19.9M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...